Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device

Thorax

Volumn 51, Issue 10, 1996, Pages 981-984

  Clark, D J ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antistatic treatment; Delayed inhalation; Lung bioavailability; Multiple actuations; Salbutamol; Spacer

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DRUG DELIVERY SYSTEM; ELECTRIC ACTIVITY; HUMAN; HUMAN EXPERIMENT; INHALATION TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0029823099     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.10.981     Document Type: Article

References (13)

1. Keeley D. Large volume plastic spacers in asthma. BMJ 1992;305:598-9.
2. Tongood J, Jennings B, Greenway R, Chuang L, Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980;65:143-53.
3. Brown P, Blundell G, Greening A, Crompton G, Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 1990;45:736-9.
4. O'Callaghan C, Milner AD, Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to children with asthma. BMJ 1989;298:160-1.
5. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax; 1993; 48:603-6.
6. O'Callaghan C, Cant M, Robertson C. Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? Thorax 1994;49:961-4.
7. Barry PW, O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the delivery of budesonide from the nebuhaler. Br J Clin pharmacol 1995; 40:76-8.
8. British Thoracic Society. Guidelines for the management of asthma. Thorax 1993;48:S1-24.
9. Barry PW, O'Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J 1994; 7:1707-9.
10. Lipworth BJ, McDeviti DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin pharmacol 1989;36:239-45.
11. Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989;37:567-71.
12. Lipworth BJ. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pubn Pharmacol 1996;9:19-27.
13. Barry PW, O'Callaghan C. Poor output of salbutamol from a spacer device the effect of spacer static charge and multiple actuations. Thorax 1994;49:402P.